Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Gut Microbiome in Lean and Overweight Youth With Type 1 Diabetes and Novel Mechanism of Action of Metformin

NCT05414409 is registered in ClinicalTrials.gov with Heba M. Ismail as lead sponsor.

NCT NCT05414409
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05414409 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Gut Microbiome in Lean and Overweight Youth With Type 1 Diabetes and Novel Mechanism of Action of Metformin
Lead sponsor
Heba M. Ismail
Phase
Phase 2
Overall status
Recruiting
Start date
September 30, 2022
Completion date
March 1, 2027
Enrollment
114 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

obesity, type 1 diabetes